News Article | May 8, 2017
PHILADELPHIA--(BUSINESS WIRE)--Independence Realty Trust, Inc. (NYSE MKT: IRT) (“IRT”) today announced that on May 5, 2017, it sold a 320-unit apartment property located in Austin, Texas for $32.0 million. IRT received net cash proceeds of $23.7 million after transaction costs and full repayment of $7.0 million of underlying property specific debt. IRT expects to recognize a gain of approximately $16.2 million associated with this sale, after transaction costs, in the quarter ended June 30, 2017. IRT used $21.0 million dollars of the proceeds from this sale to reduce its outstanding borrowings on its line of credit. The property sale is part of IRT’s previously announced strategy to sell its “C” class assets and reinvest the proceeds into “B” class assets located in IRT’s core geographic markets. This is the first of four sales, all expected to close during the second quarter. Independence Realty Trust, Inc. (NYSE MKT: IRT) is an internally-managed real estate investment trust that seeks to own well-located apartment properties in geographic submarkets that it believes support strong occupancy and the potential for growth in rental rates. IRT seeks to provide stockholders with attractive risk-adjusted returns, with an emphasis on distributions and capital appreciation. This press release may contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements can generally be identified by our use of forward-looking terminology such as “will,” “strategy,” “expects,” “seeks,” “believes,” “potential,” or other similar words. Because such statements include risks, uncertainties and contingencies, actual results may differ materially from the expectations, intentions, beliefs, plans or predictions of the future expressed or implied by such forward-looking statements. These forward looking statements are based upon the current beliefs and expectations of IRT’s management and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are difficult to predict and generally not within IRT’s control. In addition, these forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. These risks, uncertainties and contingencies include, but are not limited to, how IRT will use the net cash proceeds of the sale, whether and how IRT will be able to implement its strategy to sell properties, the ultimate accounting treatment of the property sale and those disclosed in IRT’s filings with the Securities and Exchange Commission. IRT undertakes no obligation to update these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as may be required by law.
News Article | May 12, 2017
Houston, Texas headquartered Camden Property Trust's stock edged 0.48% lower, to close the day at $81.70. The stock recorded a trading volume of 480,542 shares. Camden Property Trust's shares have advanced 0.31% in the previous three months and 4.03% in the past one year. The Company's shares are trading 0.62% and 1.56% above its 50-day and 200-day moving averages, respectively. Shares of the Company, which invests in the real estate markets of the US, are trading at a PE ratio of 17.07. Additionally, the stock has a Relative Strength Index (RSI) of 50.63. CPT complete research report is just a click away and free at: On Thursday, shares in US-based Independence Realty Trust Inc. ended the session 0.55% lower at $9.02, with a total volume of 293,050 shares traded. Independence Realty Trust's shares have gained 17.14% in the past one year. Shares of the Company, which makes investments in apartment properties to create its portfolio, are trading at a PE ratio of 80.54. The stock is trading 1.92% below its 50-day moving average and 0.90% below its 200-day moving average. Moreover, the Company's shares have an RSI of 44.22. The complimentary report on IRT can be downloaded at: On Thursday, shares in Vero Beach, Florida-based ARMOUR Residential REIT Inc. recorded a trading volume of 257,724 shares. The stock ended the day 1.04% lower at $24.82. ARMOUR Residential REIT Inc.'s stock has advanced 5.39% in the last one month and 14.06% in the previous three months. Furthermore, the stock has gained 21.19% in the past one year. The Company's shares are trading above its 50-day and 200-day moving averages by 7.15% and 10.92%, respectively. Furthermore, shares of ARMOUR Residential REIT, which invests in residential mortgage backed securities in the US, are trading at a PE ratio of 3.36. The stock has an RSI of 61.03. Sign up for your complimentary research report on ARR at: Memphis, Tennessee-based EdR's stock finished Thursday's session 1.03% lower at $37.54, with a total volume of 440,201 shares traded. The Company's shares are trading below its 50-day and 200-day moving averages by 4.90% and 8.56%, respectively. Shares of EdR, which develops, acquires, owns, and manages collegiate housing communities located near university campuses, are trading at a PE ratio of 84.55. The stock has an RSI of 39.05. On May 02nd, 2017, research firm Canaccord Genuity reiterated its 'Hold' rating on the Company's stock with a decrease of the target price from $43 a share to $42 a share. Get free access to your research report on EDR at: Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. SC has not been compensated; directly or indirectly; for producing or publishing this document. The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email email@example.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way. SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: firstname.lastname@example.org Phone number: +44-330-808-3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
News Article | May 9, 2017
NORWOOD, Mass.--(BUSINESS WIRE)--Analog Devices, Inc. (ADI) introduced today a Real-time Ethernet, Multi-protocol (REM) switch chip as part of its new generation of high performance, deterministic Ethernet connectivity solutions for connected motion and Intelligent Factory applications. The fido5000, developed by ADI’s Deterministic Ethernet Technology Group (formally Innovasic), reduces board size and power consumption while improving Ethernet performance at the node under any network load condition. It is ideally suited for synchronised, connected motion applications such as robotics and attaches to ADI’s ADSP-SC58x, ADSP-2158x and ADSP-CM40x motion control processors bringing EtherCAT, PROFINET IRT, and POWERLINK connectivity. Cycle times below 125µs are easily achievable and the chip comes with drivers to simplify integration with any Industrial Ethernet protocol stack. For Intelligent Factory applications, the fido5000 can be integrated with any processor, any protocol, and any stack making it easy to incorporate a single Industrial Ethernet interface that supports multiple protocols in any application. Since the fido5000 is “TSN-ready” it provides a means to futureproof applications as Industrial Ethernet protocols evolve to the upcoming TSN (Time Sensitive Networking) standards. About the fido5000 REM Switch The fido5000 REM switch is a 2-port embedded Ethernet switch that interfaces to any processor including ARM® CPUs and ADI’s ADSP-SC58x, ADSP-2158x and ADSP-CM40x motion control processors. The protocols it supports include PROFINET RT/IRT, EtherNet/IP with beacon-based DLR, ModbusTCP, EtherCAT, SERCOS, and POWERLINK. The REM switch comes with a software driver for each protocol that provides an API for integration with any field device or controller stack. The REM software driver have been certified by their respective sponsoring industry organization using ADI’s RapID Platform. About Analog Devices Analog Devices is the leading global high-performance analog technology company dedicated to solving the toughest engineering challenges. We enable our customers to interpret the world around us by intelligently bridging the physical and digital with unmatched technologies that sense, measure, power, connect and interpret. Visit http://www.analog.com RapID™ Platform is a trademark of Analog Devices, Inc.
News Article | May 16, 2017
"We are pleased to introduce a cloud-based hosting option for SmartSupplies to our existing and new customers," said Jeff Kinell, CEO of Bracket. "The benefits of cloud hosting continue to present themselves, especially as clinical trials worldwide rely more on immediate collaboration across sites." Bracket's hosted SmartSupplies solution is competitively priced and provides a cost-effective alternative for sponsor companies deploying the enterprise solution. This cloud-based option allows sponsors to eliminate in-house hardware maintenance and management for a reduced IT footprint. Other advantages include: The transition of SmartSupplies to the cloud is seamless for existing customers, causing no disruption to the end user. "Offering customers the option of cloud hosting for SmartSupplies was born out of necessity," said Kinell. "We want sponsors to focus their energy and efforts on running clinical trials, not on managing their IT infrastructure – and hosting SmartSupplies in the cloud will alleviate that burden." About Bracket Bracket, with nine offices and more than 700 employees worldwide, is a clinical trial technology and specialty services provider dedicated to helping biopharmaceutical sponsors and contract research organizations increase the power of their clinical research data by leveraging core competencies in Science, Technology, and Service. Bracket eCOA™ is a flexible platform for electronic clinical outcomes assessments. Bracket RTSM™ is a best-in-breed, scalable and configurable clinical IRT solution for the life sciences industry. Bracket SmartSupplies™ is a proven platform for improving a clinical supply chain. Bracket Rater Training and Quality Assurance improve outcomes through customized training and quality assurance programs. Learn more about Bracket at www.bracketglobal.com. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bracket-announces-launch-of-cloud-based-version-of-smartsupplies-300456964.html
News Article | February 15, 2017
Shinichiro Michizono from KEK has been appointed as associate director for the International Linear Collider (ILC), taking over from Mike Harrison, while Jim Brau of the University of Oregon has replaced Hitoshi Yamamoto as associate director for physics and detectors. The Linear Collider collaboration, which encompasses the ILC and CLIC, has recently been granted a further three-year mandate by the International Committee for Future Accelerators. The council of the European Southern Observatory (ESO), which builds and operates some of the world’s most powerful ground-based telescopes, has appointed Xavier Barcons as its next director general. The 57 year-old astronomer will take up his new position on 1 September 2017, when the current director general Tim de Zeeuw completes his mandate. He began his career as a physicist, completing a PhD on hot plasmas. In October 2016, Jianwei Qiu joined the Thomas Jefferson National Accelerator Facility as its new associate director for theoretical and computational physics. Qiu, whose research focus is QCD and its applications in both high-energy particle and nuclear physics, will oversee a broad programme of theoretical research in support of the physics studied with the Continuous Electron Beam Accelerator Facility (CEBAF). Rende Steerenberg has been appointed head of operations in CERN’s Beams Department, effective from 1 January 2017. He takes over from Mike Lamont, who has been in the role since 2009 and oversaw operations from the LHC’s rollercoaster start-up to its latest record performance. Lamont remains deputy group leader of the Beams Department. Former CERN Director-General Rolf-Dieter Heuer has been appointed Chevalier de la Légion d’Honneur (Knight of the Legion of Honour), one of the highest recognitions of achievement in France. Heuer, who is currently president of the German Physical Society (DPG) and president-elect of the SESAME Council, among other roles, was presented with the medal on 22 November at the residence of the French permanent representative in Geneva. The 2017 Breakthrough Prize in Fundamental Physics has been awarded to Joseph Polchinski, University of California at Santa Barbara, and Andrew Strominger and Cumrun Vafa of Harvard University. The three winners, who received the $3 million award at a glitzy ceremony in San Francisco on 4 December, have made important contributions to fundamental physics including quantum gravity and string theory. Polchinski was recognised in particular for his discovery of D-branes, while the citation for Strominger and Vafa included their derivation of the Bekenstein–Hawking area-entropy relation, which unified the laws of thermodynamics and black-hole dynamics. Recipients of the previously announced Special Prize in Fundamental Physics – Ronald Drever and Kip Thorne of Caltech and Rainer Weiss of MIT, who were recognised in May along with the entire LIGO team for the discovery of gravitational waves – were also present. A further prize, the $100,000 New Horizons in Physics Prize, went to six early-career physicists: Asimina Arvanitaki (Perimeter Institute), Peter Graham (Stanford University) and Surjeet Rajendran (University of California, Berkeley); Simone Giombi (Princeton University) and Xi Yin (Harvard University); and Frans Pretorius (Princeton). This year’s Breakthrough Prize, which was founded in 2012 by Sergey Brin, Anne Wojcicki, Yuri and Julia Milner, Mark Zuckerberg and Priscilla Chan, saw $25 million in prizes awarded for achievements in the life sciences, fundamental physics and mathematics. On 30 November, the Alexander von Humboldt Foundation in Bonn, Germany, granted a Humboldt Research Award to Raju Venugopalan, a senior physicist at Brookhaven National Laboratory and Stony Brook University. The €60,000 award recognises Venugopalan’s achievements in theoretical nuclear physics, and comes with the opportunity to collaborate with German researchers at Heidelberg University and elsewhere. US physicist and science policy adviser to the US government, Richard Garwin, was awarded the Presidential Medal of Freedom at a White House ceremony on 22 November. The award is the highest honour that the US government can confer to civilians. Garwin was recognised for his long career in research and invention, which saw him play a leading role in the development of the hydrogen bomb, and for his advice to policy makers. Introducing Garwin, President Obama remarked: “Dick’s not only an architect of the atomic age. Reconnaissance satellites, the MRI, GPS technology, the touchscreen all bear his fingerprints – he even patented a mussel washer for shellfish. Dick has advised nearly every president since Eisenhower, often rather bluntly. Enrico Fermi, also a pretty smart guy, is said to have called Dick the only true genius he ever met.” Fumihiko Suekane of Tohoku University, Japan, has been awarded a 2016 Blaise Pascal Chair to further his research into neutrinos. Established in 1996, and named after the 17th-century French polymath Blaise Pascal, the €200,000 grant allows researchers from abroad to work on a scientific project in an institution in the Ile-de-France region. Suekane will spend a year working at the Astroparticle and Cosmology Laboratory in Paris, where he will focus on R&D for novel neutrino detectors and measurements of reactor neutrinos. In late 2016, theorists Mikhail Danilov, from the Lebedev Institute in Moscow, Sergio Ferrara from CERN and David Gross from the Kavli Institute for Theoretical Physics and the University of California in Santa Barbara were elected as members of the Russian Academy of Sciences. Established in 1724, the body has more than 2000 members. President of the Republic of Poland, Andrzej Duda, visited CERN on 15 November and toured the CERN Control Centre. Chi-Chang Kao, signed the guestbook with CERN Director-General Fabiola Gianotti on 23 November. From 28 November to 2 December, more than 200 flavour physicists gathered at the Tata Institute of Fundamental Research in Mumbai for the 9th International Workshop on the Cabibbo–Kobayashi–Maskawa Unitarity Triangle (CKM2016). The workshop focuses on weak transitions of quarks from one flavour to another, as described by the CKM matrix, and on the charge–parity (CP) violation present in these transitions, as visualised by the unitarity triangle (UT). Input from theory, particularly lattice QCD, is vital to fully leverage the power of such measurements. It is an exciting time for flavour physics. The mass scales potentially involved in such weak processes are much higher than those that can be directly probed at the LHC, due to the presence of quantum loops that mediate many of the processes of interest, such as B0 – B0 mixing. Compared with the absence of new particles so far at the energy frontier, LHCb and other B factories already have significant hints of deviations between measurements and Standard Model (SM) predictions. An example is the persistent discrepancy in the measured differential distributions of the decay products of the rare flavour-changing neutral-current process B0 → K*0 μ+ μ–, first reported by the LHCb collaboration in 2015. A highlight of CKM2016 was the presentation of first results of the same distributions from the Belle experiment in Japan, which also included the related but previously unmeasured process B0 → K*0 e+ e–. The Belle results are more compatible with those of LHCb than the SM, further supporting the idea that new physics may be manifesting itself, via interference effects, in these observables. Progress on measuring CP violation in B decays was also reported, with LHCb presenting the first evidence for time-dependent CP violation in the decay of B0 mesons in two separate final states, D+ K– and K+ K–. The latter involves loop diagrams allowing a new-physics-sensitive determination of a UT angle (γ) that can be compared to a tree-level SM determination in the decay B– → D0 K–. For the first time, LHCb also presented results with data from LHC Run 2, which is ultimately expected to increase the size of the LHCb data samples by approximately a factor four. Longer term, the Belle II experiment based at the SuperKEKB collider recently enjoyed its first beam, and will begin its full physics programme in 2018. By 2024, Belle II should have collected 50 times more data than Belle, allowing unprecedented tests of rare B-meson decays and precision CP-violation measurements. On the same timescale, the LHCb upgrade will also be in full swing, with the goal of increasing the data size by least a factor 10 compared to Run 1 and Run 2. Plans for a second LHCb upgrade presented at the meeting would allow LHCb, given the long-term future of the LHC, to run at much higher instantaneous luminosities to yield an enormous data set by 2035. With more data the puzzles of flavour physics will be resolved thanks to the ongoing programme of LHCb, imminent results from rare-kaon-decay experiments (KOTO and NA62), and the Belle II/LHCb upgrade projects. No doubt there will be more revealing results by the time of the next CKM workshop, to be held in Heidelberg in September 2018. While there are many conferences focusing on physics at the high-energy frontier, the triennial PSI workshop at the Paul Scherrer Institute (PSI) in Switzerland concerns searches for new phenomena at non-collider experiments. These are complementary to direct searches at the LHC and often cover a parameter space that is beyond the reach of the LHC or even future colliders. The fourth workshop in this series, PSI2016, took place from 16–21 October and attracted more than 170 physicists. Theoretical overviews covered: precision QED calculations; beyond-the-Standard-Model implications of electric-dipole-moment (EDM) searches; axions and other light exotic particles; flavour symmetries; the muon g-2 problem; NLO calculations of the rare muon decay μ → eeeνν; and possible models to explain the exciting flavour anomalies presently seen in B decays. On the experimental side, several new results were presented. Fundamental neutron physics featured prominently, ranging from cold-neutron-beam experiments to those with stored ultracold neutrons at facilities such as ILL, PSI, LANL, TRIUMF and Mainz. Key experiments are measurements of the neutron lifetime, searches for a permanent EDM, measurements of beta-decay correlations and searches for exotic interactions. The future European Spallation Source in Sweden will also allow a new and much improved search for neutron–antineutron oscillations. Atomic physics and related methods offer unprecedented sensitivity to fundamental-physics aspects ranging from QED tests, parity violation in weak interactions, EDM and exotic physics to dark-matter (DM) and dark-energy searches. With the absence of signals from direct DM searches so far, light and ultralight DM is a focus of several upcoming experiments. Atomic physics also comprises precision spectroscopy of exotic atoms, and several highlight talks included the ongoing efforts at CERN’s Antiproton Decelerator with antihydrogen and with light muonic atoms at J-PARC and at PSI. For antiprotons and nuclei, impressive results from recent Penning-trap mass and g-factor measurements were presented with impacts on CPT tests, bound-state QED tests and more. Major international efforts are under way at PSI (μ → eγ, μ → eee), FNAL and J-PARC (μ → e conversion) devoted to muons and their lepton-flavour violating decays, and the upcoming muon g-2 experiments at FNAL and J-PARC have reported impressive progress. Last but not least, rare kaon decays (at CERN and J-PARC), new long-baseline neutrino oscillation results, developments towards direct neutrino-mass measurements, and CP and CPT tests with B mesons were reported. The field of low-energy precision physics has grown fast over the past few years, and participants plan to meet again at PSI in 2019. The fields of nanomaterials and nanotechnology are quickly evolving, with discoveries frequently reported across a wide range of applications including nanoelectronics, sensor technologies, drug delivery and robotics, in addition to the energy and healthcare sectors. At an academia–industry event on 20–21 October at GSI in Darmstadt, Germany, co-organised by the technology-transfer network HEPTech, delegates explored novel connections between nanotechnology and high-energy physics (HEP). The forum included an overview of the recent experiments at DESY’s hard X-ray source PETRA III, which allows the investigation of physical and chemical processes in situ and under working conditions and serves a large user community in many fields including nanotechnology. Thermal-scanning probe lithography, an increasingly reliable method for rapid and low-cost prototyping of 2D and quasi-3D structures, was also discussed. Much attention was paid to the production and application of nanostructures, where the achievements of the Ion Beam Center at Helmholtz-Zentrum Dresden-Rossendorf in surface nanostructuring and nanopatterning were introduced. UK firm Hardide Coatings Ltd presented its advanced surface-coating technology, the core of which are nano-structured tungsten-carbide-based coatings that have promising applications in HEP and vacuum engineering. Industry also presented ion-track technology, which is being used to synthesise 3D interconnected nanowire networks in micro-batteries or gas sensors, among other applications. Neutron-research infrastructures and large-scale synchrotrons are emerging as highly suitable platforms for the advanced characterisation of micro- and nano-electronic devices, and the audience heard the latest developments from the IRT Nanoelec Platform for Advanced Characterisation of Grenoble. The meeting addressed how collaboration between academia and industry in the nanotechnology arena can best serve the needs of HEP, with CERN presenting applications in gaseous detectors using the charge-transfer properties of graphene. The technology-transfer office at DESY also shared its experience in developing a marketing strategy for promoting the services of the DESY NanoLab to companies. Both academia and industry representatives left the event with a set of contacts and collaboration arrangements. On 24–25 November, academics and leading companies in the field of superconductivity met in Madrid, Spain, to explore the technical challenges of applying new accelerator technology to medicine. Organised by CIEMAT in collaboration with HEPTech, EUCARD2, CDTI, GSI and the Enterprise Europe Network, the event brought together 120 participants from 19 countries to focus on radioisotope production, particle therapy and gantries. Superconductivity has a range of applications in energy, medicine, fusion and high-energy physics (HEP). The latter are illustrated by CERN’s high-luminosity LHC (HL-LHC), now near construction with superconducting magnets made from advanced Nb Sn technology capable of 12 T fields. The HL-LHC demands greatly advanced superconducting cavities with more efficient and higher-gradient RF systems, plus the development of new devices such as crab cavities that can deflect or rotate single bunches of protons. On the industry side, new superconducting technology is ready to go into production for medical applications. A dedicated session presented novel developments in cyclotron production, illustrated by the AMIT project of CIEMAT (based on a cyclotron with a compact superconducting design that will be able to produce low-to-moderate rates of dose-on-demand 11C and 18F) and the French industry–academia LOTUS project system, which features a compact 12 MeV superconducting helium-free magnet cyclotron suitable for the production of these isotopes in addition to 68Ga. Antaya Science and Technology, meanwhile, reported on the development of a portable high-field superconducting cyclotron for the production of ammonia-13N in near proximity to the PET cameras. The meeting also heard from MEDICIS, the new facility under construction at CERN that will extend the capabilities of the ISOLDE radioactive ion-beam facility for production of radiopharmaceuticals and develop new accelerator technologies for medical applications (CERN Courier October 2016 p28). Concerning particle therapy, industry presented medical accelerators such as the MEVION S250 – a proton-therapy system based on a gantry-mounted 250 MeV superconducting synchrocyclotron that weighs less than 15 tonnes and generates magnetic fields in excess of 10 T. Global medical-technology company IBA described its two main superconducting cyclotrons for particle therapy: the Cyclone 400 for proton/carbon therapy and the S2C2 dedicated to proton therapy, with a particular emphasis on their superconducting coil systems. IBA also introduced the latest developments concerning ProteusONE – a single-room system that delivers the most clinically advanced form of proton-radiation therapy. Researchers from MIT in the US presented a novel compact superconducting synchrocyclotron based on an ironless magnet with a much reduced weight, while the TERA Foundation in Italy is developing superconducting technology for “cyclinacs” – accelerators that combine a cyclotron injector and a linac booster. Finally, the session on gantries covered developments such as a superconducting bending-magnet section for future compact isocentric gantries by researchers at the Paul Scherrer Institute, and a superconducting rotating gantry for carbon radiotherapy designed by the Japanese National Institute of Radiological Sciences. With demand for medical isotopes and advanced cancer therapy rising, we can look forward to rich collaborations between accelerator physics and the medical community in the coming years. The fifth in the series of Higgs Couplings workshops, which began just after the Higgs-boson discovery in 2012 to bring together theorists and experimentalists, was held at SLAC on 9–12 November and drew 148 participants from five continents. Discussions focused on lessons from the current round of LHC analyses that could be applied to future data. Modelling of signal and background is already limiting for some measurements, and new theoretical results and strategies were presented. Other key issues were the use of vector-boson fusion production as a tool, and the power and complementarity of diverse searches for heavy Higgs bosons. Two new themes emerged at the meeting. The first was the possibility of exotic decays of the 125 GeV Higgs boson. These include not only Higgs decays to invisible particles but also decays to lighter Higgs particles, light quarks and leptons (possibly with flavour violation) and new, long-lived particles. A number of searches from ATLAS and CMS reported their first results. The workshop also debated the application of effective field theory as a framework for parametrising precise Higgs measurements. The 6th Higgs Couplings meeting will be held in Heidelberg on 6–10 November 2017. We look forward to new ideas for the creative use of the large data samples of Higgs bosons that will become available as the LHC programme continues. The 8th International Conference on Hard and Electromagnetic Probes of High-energy Nuclear Collisions (Hard Probes 2016) was held in Wuhan, China, on 23–27 September. Hard and electromagnetic probes are powerful tools for the study of the novel properties of hot and dense QCD matter created in high-energy nucleus–nucleus collisions, and have provided much important evidence for the formation of quark–gluon plasma (QGP) in heavy-ion collisions at RHIC and the LHC. Hard Probe 2016 attracted close to 300 participants from 28 countries. The main topics discussed were: jet production and modification in QCD matter; high transverse-momentum hadron spectra and correlations; jet-induced medium excitations; jet properties in small systems; heavy flavour hadrons and quarkonia; photons and dileptons and initial states and related topics. The most recent experimental progress on hard and electromagnetic probes from the ALICE, ATLAS, CMS, LHCb, PHENIX and STAR collaborations, together with many new exciting theoretical and phenomenological developments, were discussed. The next Hard Probe conference will be held in Aix Les Bains, France, in 2018. The International Symposium on EXOtic Nuclei (EXON-2016), took place from 5–9 September in Kazan, Russia, attracting around 170 nuclear experts from 20 countries. The scientific programme focused on recent experiments on the synthesis and study of new super-heavy elements, the discovery of which demonstrates the efficiency of international co-operation. Interesting results were obtained in joint experiments on chemical identification of elements 112 and 114 performed at JINR (Russia), the GSI (Germany) and the Paul Scherrer Institute (Switzerland). A vivid example of co-operation with US scientists is an experiment on the synthesis of element 117 held at the cyclotron of JINR. Recently, the International Union of Pure and Applied Chemistry approved the discovery of the new elements with atomic numbers 113 (“nihonian”), 115 (“moscovium”), 117 (“tennessine”) and 118 (“oganesson”). Five laboratories, which are the co-founders of the symposium, are now creating a new generation of accelerators for the synthesis and study of new exotic nuclei. Projects such as SPIRAL2, RIKEN RI Beam Factory, FAIR, DRIBs, NICA and FRIB will allow us to delve further into the upper limits of the periodic table. The CERN Accelerator School (CAS) and the Wigner Research Centre for Physics jointly organised an introduction-to-accelerator-physics course in Budapest, Hungary, from 2–14 October, attended by more than 120 participants spanning 28 nationalities. This year, CAS will organise a specialised course on beam injection, extraction and transfer (to be held in Erice, Sicily, from 10–19 March) and a second specialised course on vacuum for particle accelerators (near Lund, Sweden, from 6–16 June). The next course on advanced-accelerator physics will be held in the UK in early September, and a Joint International Accelerator School on RF technology will be held in Hayama, Japan, from 16–26 October (www.cern.ch/schools/CAS).
News Article | February 27, 2017
From March 1 to 5 in Vienna (Austria) Guerbet (FR0000032526 GBT), a global specialist in contrast products and solutions for medical imaging, has announced its participation in the European Congress of Radiology (ECR), the flagship event for more than 20,000 medical imaging professionals from 133 countries. The congress will be held from March 1 to 5, 2017 at the Austria Center Vienna (Vienna, Austria). It will enable Guerbet to inform the radiologist community of its innovations and its status as a new leader in imaging, present in 80 countries. The Group, which has 2,600 employees, has just celebrated its 90th anniversary and reached a milestone in its development by successfully integrating Mallinckrodt's "Contrast Media and Delivery Systems" business, acquired at the end of 2015. At the ECR, Guerbet will present its solutions and services for X-ray imaging (CT-scan and angiography), MRI and Interventional Radiology and Theranostics. Guerbet will detail its progress in the flourishing Imaging Solutions and Services segment: The latest news on MRI contrast products will be presented at a symposium organized by Guerbet on Friday March 3 by several international neuroradiology experts. In Interventional Radiology and Theranostic, Guerbet will give details on its growing commitment in hepatic oncology but also in women's health with the use of its products for the radiography of the cavities of the uterus and the fallopian tubes (hysterosalpingography). Finally, a new web and mobile application, "Radiology Events", will be unveiled. It will enable professionals to access information on radiology events, international congresses, local training sessions ... and to propose their own events. Guerbet is a pioneer in the contrast agent field, with 90 years' experience, and is the only pharmaceutical group dedicated to medical imaging worldwide. It offers a comprehensive range of X-Ray, Magnetic Resonance Imaging (MRI) and Interventional Radiology and Theranostic (IRT) products, along with a range of injectors and related medical devices to improve the diagnosis and treatment of patients. To discover new products and ensure future growth, Guerbet invests heavily in R&D, spending around 9% of its sales each year. Guerbet (GBT) is listed on Euronext Paris (Segment B - Mid Caps) and generated €776 million in revenue in 2016. For more information about Guerbet, please visit http://www.guerbet.com
News Article | February 28, 2017
PHILADELPHIA--(BUSINESS WIRE)--Independence Realty Trust, Inc. (“IRT”) (NYSE MKT: IRT) today announced that, on February 27, 2017, IRT acquired an apartment community located in Tampa, Florida for a purchase price of $29.75 million. IRT used available cash and its line of credit to acquire the community. Located in Tampa, Florida the 216 unit apartment community was constructed in 1985 and was extensively renovated in 2016. Situated in the Northdale neighborhood of Tampa and more specifically in the Dale Mabry retail corridor, the community benefits from its close proximity to retail, highly rated schools and easy access to Tampa’s major highways. The property contains one and two bedroom units with an average unit size of 925 square feet. As of February 22, 2017, the occupancy of the property was 93% and had an average effective rent per occupied unit of $1,192 ($1.29/sf) for the three months ending January 31, 2017. “This acquisition represents our commitment to improve the quality of the portfolio as we divest of our class C communities and reinvest into Class B communities that are in well located, mature neighborhoods with limited competition from new construction,” said Scott Schaeffer, Chairman and CEO of IRT. Independence Realty Trust, Inc. (NYSE MKT: IRT) is an internally-managed real estate investment trust that seeks to own well-located apartment properties in geographic submarkets that it believes support strong occupancy and the potential for growth in rental rates. IRT seeks to provide stockholders with attractive risk-adjusted returns, with an emphasis on distributions and capital appreciation.
News Article | February 24, 2017
PHILADELPHIA--(BUSINESS WIRE)--RAIT Financial Trust (RAIT) (NYSE: RAS) today announced that its Board of Directors has approved a comprehensive strategy and transformation initiative to drive long-term revenue growth and enhance shareholder value. Pursuant to this initiative, following the strategy that RAIT began pursuing in 2016, RAIT will continue to transform into a more focused, cost-efficient and lower leverage business concentrated on its core commercial real estate lending business. In connection with executing its strategy and transformation initiative, RAIT has identified several key priorities designed to differentiate RAIT, improve RAIT’s margins and enhance shareholder value over time by delivering stable and repeatable risk-adjusted returns. Our transformational strategy is focused on the following priorities: “We believe our strategy of transforming RAIT into a pure-play commercial real estate lender is the right strategy to differentiate RAIT, drive sustainable earnings and, ultimately, grow long-term shareholder value.” said Scott Davidson, RAIT’s Chief Executive Officer. “As we detail in our investor presentation and will discuss during our fourth quarter 2016 earnings call, we have achieved significant progress in 2016 in implementing our strategy and transformation initiative and look to carry that momentum into 2017.” RAIT has posted to its website an updated investor presentation which provides key elements of RAIT’s comprehensive strategy and transformation initiative. The full presentation, which RAIT will be using with shareholders as part of RAIT’s ongoing program to meet with investors and solicit their views and opinions regarding its strategy for enhancing shareholder value, is available on RAIT’s home page and in RAIT’s investor relations website in the “Presentations” section. Shareholders and other stakeholders are encouraged to read the entire presentation. RAIT plans to discuss its strategy and transformation initiative further during its fourth quarter 2016 earnings call. Interested parties can listen to the live conference call via webcast at 9:30 AM ET on Friday, February 24, 2017 from the home page of the RAIT Financial Trust website at www.rait.com or by dialing 1.844.775.2541, access code 64221042. For those who are not available to listen to the live call, the replay will be available shortly following the live call on RAIT’s website and telephonically until Friday, March 3, 2017, by dialing 855.859.2056, access code 64221042. RAIT Financial Trust is an internally-managed real estate investment trust focused on providing debt financing options to owners of commercial real estate throughout the United States. For more information, please visit www.rait.com or call Investor Relations at 215.207.2100. This press release may contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements can generally be identified by our use of forward-looking terminology such as “2017 expectations,” “guidance,” “may,” “plan”, “should,” “expect,” “intend,” “anticipate,” “estimate,” “believe,” “seek,” “opportunities” or other similar words or terms. Because such statements include risks, uncertainties and contingencies, actual results may differ materially from the expectations, intentions, beliefs, plans or predictions of the future expressed or implied by such forward-looking statements. RAIT’s forward-looking statements include, but are not limited to, statements regarding RAIT’s plans and initiatives and 2017 expectations to (i) simplify its business model, (ii) focus on its core commercial real estate lending business, (iii) increase loan origination levels, when compared to 2016, as capital from non-lending related asset sales is re-deployed, (iv) deleverage by using cash generated by asset sales to repay debt, (v) opportunistically divest and maximize the value of RAIT’s legacy REO portfolio and existing property management operations and, ultimately, minimize REO holdings, (vi) significantly reduce its total expense base, (vii) continue to sell non-lending assets, (viii) achieve significant annual expense savings in connection with the internalization of IRT, (ix) sell in whole or substantial part its Urban Retail commercial property management business and achieve costs savings in connection with such sale, and (x) enhance its long-term prospects and create value for its shareholders. Such forward-looking statements are based upon RAIT’s historical performance and its current plans, estimates, predictions and expectations and are not a representation that such plans, estimates, predictions or expectations will be achieved. Because such statements include risks, uncertainties and contingencies, actual results may differ materially from the expectations, intentions, beliefs, plans or predictions of the future expressed or implied by such forward-looking statements. Risks, uncertainties and contingencies that may affect the results expressed or implied by RAIT’s forward-looking statements include, but are not limited to: (i) whether RAIT will be able to continue to implement its strategy to transition RAIT to a more lender focused, simpler, and more cost-efficient business model, to deleverage and to generate enhanced returns for its shareholders; (ii) whether RAIT will be able to continue to opportunistically divest and maximize the value of RAIT’s legacy REO portfolio and existing property management operations and the majority of RAIT’s non-lending assets; (iii) whether anticipated cost savings from the internalization of IRT will be achieved; (iv) whether the divestiture of RAIT’s CRE portfolio and other non-lending assets will lead to lower asset management costs and lower expenses; (v) whether RAIT will be able to reduce compensation and G&A expenses and indebtedness; (vi) whether RAIT’s new leadership will lead to enhanced value for shareholders; (vii) whether RAIT will be able to create sustainable earnings and grow book value; (viii) whether RAIT will be able to redeploy capital from non-lending related asset sales; (ix) whether RAIT will be able to increase loan origination levels; (x) whether the disposition of non-core assets, reductions in debt levels and expected loan repayments will impact RAIT’s earning and CAD; (xi) whether RAIT will continue to pay dividends and the amount of such dividends; (xii) whether RAIT will be able to organically increase reliance on match-funded asset-level debt; (xiii) overall conditions in commercial real estate and the economy generally; (xiv) whether market conditions will enable us to continue to implement our capital recycling and debt reduction plan involving selling properties and repurchasing or paying down our debt; (xv) whether we will be able to originate sufficient bridge loans; (xvi) whether the timing and amount of investments, repayments, any capital raised and our use of leverage will vary from those underlying our assumptions; (xvii) changes in the expected yield of our investments; (xviii) changes in financial markets and interest rates, or to the business or financial condition of RAIT or its business; (xix) whether RAIT will be able to originate loans in the amounts assumed; (xx) whether RAIT will generate any CMBS gain on sale profits; (xxi) whether the amount of loan repayments will be at the level assumed; (xxii) whether our management changes will be successfully implemented; (xxiii) whether RAIT will be able to dispose of its industrial portfolio or sell the other properties; (xxiv) the availability of financing and capital, including through the capital and securitization markets; (xxv) risks, disruption, costs and uncertainty caused by or related to the actions of activist shareholders, including that if individuals are elected to our Board with a specific agenda, it may adversely affect our ability to effectively implement our business strategy and create value for our shareholders and perceived uncertainties as to our future direction as a result of potential changes to the composition of our Board may lead to the perception of a change in the direction of our business, instability or a lack of continuity which may be exploited by our competitors, cause concern to our current or potential customers, and may result in the loss of potential business opportunities and make it more difficult to attract and retain qualified personnel and business partners; and (xxvi) other factors described in RAIT’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and in other filings with the SEC. RAIT undertakes no obligation to update these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as may be required by law.
News Article | February 22, 2017
PHILADELPHIA--(BUSINESS WIRE)--RAIT Financial Trust (NYSE: RAS) (“RAIT”), a national direct lender to owners of commercial real estate and an internally-managed real estate investment trust, announced today that RAIT entered into an agreement to sublease all of its office space, approximately 4,697 square feet, at 600 Third Avenue in New York City, which sublease commenced as of February 21, 2017. “We are pleased to announce the subleasing of RAIT’s New York office space,” said Scott Davidson, RAIT’s Chief Executive Officer and President. “This transaction represents another step in our ongoing strategy to analyze and adjust our cost structure as we transition to focusing on our commercial real estate lending business which is a simpler, cost efficient and lower leverage business model and, ultimately, position RAIT to generate enhanced returns for our shareholders. RAIT expects to achieve significant annual expense savings from actions taken to date including the internalization of Independence Realty Trust’s management.” RAIT Financial Trust (NYSE: RAS) is an internally managed real estate investment trust that provides debt financing options to owners of commercial real estate and owns a portfolio of commercial real estate properties located throughout the United States. Additional information about RAIT can be found on its website at www.rait.com. This press release may contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements can generally be identified by our use of forward-looking terminology such as “ongoing strategy,” “transition,” “ultimately,” “positioning,” “expects,” “intend,” “anticipate,” “estimate,” “believe,” “seek,” “opportunities” or other similar words or terms. Such forward-looking statements include, but are not limited to, statements regarding RAIT’s initiatives to focus on its commercial real estate lending business, reduce costs, deleverage and enhance value for shareholders, RAIT’s actions taken or contemplated to enhance its long-term prospects and create value for its shareholders and RAIT’s ability to achieve significant annual expense savings from actions taken to date, including the internalization of Independence Realty Trust, Inc. (“IRT”). Such forward-looking statements are based upon RAIT’s historical performance and its current plans, estimates and expectations and are not a representation that such plans, estimates, or expectations will be achieved. Because such statements include risks, uncertainties and contingencies, actual results may differ materially from the expectations, intentions, beliefs, plans or predictions of the future expressed or implied by such forward-looking statements. These risks, uncertainties and contingencies include, but are not limited to: whether RAIT will be able to continue to implement its strategy to transition RAIT to a more lender focused, simpler, and more cost efficient business model, to deleverage and to generate enhanced returns for its shareholders, whether anticipated cost savings from actions previously taken, including the internalization of IRT, will be achieved, and other factors described in RAIT’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and in other filings with the SEC. RAIT undertakes no obligation to update these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as may be required by law.
News Article | March 2, 2017
— Market Research Future published a half cooked research report on global cystic fibrosis market. The global market for cystic fibrosis market is expected to reach approximately USD 3.8 billion during the period 2016 to 2022. Test the market data and market information presented through more than 50 market data tables and figures spread over 85 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Cystic fibrosis Market Research Report –Global Forecast to 2022”. Market Highlights: The global cystic fibrosis market has been evaluated as rapidly growing market and expected that the market will reach high growth figures. There has been a tremendous growth in the number of people getting diagnosed with cystic fibrosis. It is a genetic defect and caused due to the mutation in the CFTR gene. Development of the cystic fibrosis has a lot to do with the family history with respect to disorder. Cystic fibrosis is more common among Caucasians of Northern European descent. But it is known to occur in all ethnic and racial groups. Market Research Analysis: In the coming years, the cystic fibrosis market will advance globally more than it has in the past several years. There is no specific age for the development of the cystic fibrosis. It can develop at any age. However people above age 45 are more prone to the cystic fibrosis. North America is the region leading the market of cystic fibrosis. However, the prevalence of cystic fibrosis is increasing rapidly in the Asia-Pacific region where India being the major country having huge number of patients diagnosed with the disease. Brief TOC for Cystic Fibrosis: 1 Introduction 1.1 Definitions 1.2 Scope of Study 1.2.1 Research Objective 1.2.2 Assumptions & Limitations 184.108.40.206 Assumptions 220.127.116.11 Limitations 1.3 Market Structure: 2 Research Methodology 2.1 Research Process: 2.2 Primary Research 2.3 Secondary Research: 3 Market Dynamics 3.1 Drivers 3.2 Restraints 3.3 Opportunities 3.4 Macroeconomic Indicators 4 Market Factor Analysis 4.1 Porters Five Forces Model 4.2 Bargaining Power Of Suppliers 4.3 Bargaining Power Of Buyers 4.4 Threat Of New Entrants 4.5 Threat Of Substitutes 4.6 Intensity Of Rivalry 5 Global Cystic Fibrosis Market, By Diagnostic Test 5.1 Immunoreactive Trypsinogen (Irt) Test 5.2 Sweat Chloride Test 5.3 Sputum Test 5.4 Chest X-Ray 5.5 Ct Scan 5.6 Pulmonary Function Test Continue… Segments: Cystic Fibrosis Market has been segmented on the basis of diagnostic test which comprises of immunoreactive trypsinogen (IRT) test, sweat chloride test, sputum test, chest X-ray, CT scan and pulmonary function test. On the basis of treatments, market is segmented into medical therapy, surgical treatment and others. On the basis of drug type, market is segmented into small molecules and biologics. Intended Audience: • Cystic fibrosis manufacturers & suppliers • Contract Research Organizations (CROs) • Research and Development (R&D) Companies • Government Research Laboratories • Independent Research Laboratories • Government and Independent Regulatory Authorities • Market Research and Consulting Service Providers • Academic Institutes and Universities About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. For more information, please visit https://www.marketresearchfuture.com/